Anti-DPB1/ HLA-DPB1/ HLA-DP monoclonal antibody

Anti-DPB1/ HLA-DPB1/ HLA-DP antibody for FACS & in-vivo assay

Target products collectionGo to HLA-DPB1/HLA-DPB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0584-Ab-1/ GM-Tg-hg-MP0584-Ab-2Anti-Human HLA-DPB1 monoclonal antibodyHuman
GM-Tg-rg-MP0584-Ab-1/ GM-Tg-rg-MP0584-Ab-2Anti-Rat HLA-DPB1 monoclonal antibodyRat
GM-Tg-mg-MP0584-Ab-1/ GM-Tg-mg-MP0584-Ab-2Anti-Mouse HLA-DPB1 monoclonal antibodyMouse
GM-Tg-cynog-MP0584-Ab-1/ GM-Tg-cynog-MP0584-Ab-2Anti-Cynomolgus/ Rhesus macaque HLA-DPB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0584-Ab-1/ GM-Tg-felg-MP0584-Ab-2Anti-Feline HLA-DPB1 monoclonal antibodyFeline
GM-Tg-cang-MP0584-Ab-1/ GM-Tg-cang-MP0584-Ab-2Anti-Canine HLA-DPB1 monoclonal antibodyCanine
GM-Tg-bovg-MP0584-Ab-1/ GM-Tg-bovg-MP0584-Ab-2Anti-Bovine HLA-DPB1 monoclonal antibodyBovine
GM-Tg-equg-MP0584-Ab-1/ GM-Tg-equg-MP0584-Ab-2Anti-Equine HLA-DPB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0584-Ab-1/ GM-Tg-hg-MP0584-Ab-2; GM-Tg-rg-MP0584-Ab-1/ GM-Tg-rg-MP0584-Ab-2;
GM-Tg-mg-MP0584-Ab-1/ GM-Tg-mg-MP0584-Ab-2; GM-Tg-cynog-MP0584-Ab-1/ GM-Tg-cynog-MP0584-Ab-2;
GM-Tg-felg-MP0584-Ab-1/ GM-Tg-felg-MP0584-Ab-2; GM-Tg-cang-MP0584-Ab-1/ GM-Tg-cang-MP0584-Ab-2;
GM-Tg-bovg-MP0584-Ab-1/ GM-Tg-bovg-MP0584-Ab-2; GM-Tg-equg-MP0584-Ab-1/ GM-Tg-equg-MP0584-Ab-2
Products NameAnti-HLA-DPB1 monoclonal antibody
Formatmab
Target NameHLA-DPB1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HLA-DPB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DPB1/ HLA-DPB1/ HLA-DP VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004458human HLA-DPB1 Lentivirus plasmid
    ORF Viral VectorvGMLP004458human HLA-DPB1 Lentivirus particle


    Target information

    Target IDGM-MP0584
    Target NameHLA-DPB1
    Gene ID3115,717969,111556176
    Gene Symbol and SynonymsDPB1,HLA-DP,HLA-DP1B,HLA-DPB,HLA-DPB1,LOC111556176,MAMU-DPB,Mamu-DPB1
    Uniprot AccessionP04440
    Uniprot Entry NameDPB1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000223865
    Target ClassificationTumor-associated antigen (TAA)

    The target: HLA-DPB1, gene name: HLA-DPB1, also named as DPB1, HLA-DP, HLA-DP1B, HLA-DPB. HLA-DPB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DP molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.